Literature DB >> 7152669

Characterization of the lipopolysaccharide from Vibrio cholerae 395 (Ogawa).

S Kabir.   

Abstract

The chemical structure and biological properties of the lipopolysaccharide (LPS) from Vibrio cholerae 395 (Ogawa), isolated by the phenol-water procedure, were studied. Upon acid hydrolysis, the LPS was split into its polysaccharide and lipid A moieties. The polysaccharide contained both neutral (glucose, heptose, fructose) and amino (glucosamine, quinovosamine) sugars. The LPS contained the acid-labile amino sugar, 4-amino-arabinose, which was absent in the Inaba serotype of V. cholerae. The LPS differed from the LPSs of Enterobacteriaceae by the absence of 2-keto-3-deoxyoctonate and the presence of fructose. Analysis of the methylated polysaccharide by gas-liquid chromatography and mass spectrometry showed that it had a branched structure with glucose and heptose residues primarily appearing at the nonreducing-end groups. Interactions with lectins, concanavalin A. and wheat germ agglutinin suggested that terminal glucose residues were alpha linked, whereas terminal glucosamine residues were connected by alpha-1,3 linkages. The major fatty acids of the LPS were C14:0, C16:0, C12h:0, and C14h:0 compounds, of which only the C14h:0 were amide linked, the remainder being ester linked to the backbone. Biological studies showed that the LPS possessed endotoxic properties such as lethality, pyrogenicity, limulus lysate gelation, and ability to induce non-specific resistance to infection. Thus, the LPS from V. cholerae 395 (Ogawa) possessed both common and distinct features as compared with the LPSs from the Enterobacteriaceae.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7152669      PMCID: PMC347884          DOI: 10.1128/iai.38.3.1263-1272.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Multiple serotypes of vibrio cholerae isolated from a case of cholera. Evidence suggesting in-vivo mutation.

Authors:  E J Gangarosa; A Sanati; H Saghari; J C Feeley
Journal:  Lancet       Date:  1967-03-25       Impact factor: 79.321

2.  Isolation of a phenol-soluble endotoxin from Leptotrichia buccalis.

Authors:  K W Knox; R B Parker
Journal:  Arch Oral Biol       Date:  1973-01       Impact factor: 2.633

3.  Cell walls, lipids, and lipopolysaccharides of Pseudomonas species.

Authors:  S G Wilkinson; L Galbraith; G A Lightfoot
Journal:  Eur J Biochem       Date:  1973-02-15

4.  The 1968-1969 cholera-vaccine field trial in rural East Pakistan. Effectiveness of monovalent Ogawa and Inaba vaccines and a purified Inaba antigen, with comparative results of serological and animal protection tests.

Authors:  W H Mosley; W E Woodward; K M Aziz; A S Rahman; A K Chowdhury; A Ahmed; J C Feeley
Journal:  J Infect Dis       Date:  1970-05       Impact factor: 5.226

5.  Pathogenesis of experimental cholera: biologic ativities of purified procholeragen A.

Authors:  R A Finkelstein; P Atthasampunna; M Chulasamaya; P Charunmethee
Journal:  J Immunol       Date:  1966-03       Impact factor: 5.422

6.  Nature and linkages of the fatty acids present in the lipid-A component of Salmonella lipopolysaccharides.

Authors:  E T Rietschel; H Gottert; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1972-07-13

7.  Somatic antigen variation in Vibrio cholerae.

Authors:  R Sakazaki; K Tamura
Journal:  Jpn J Med Sci Biol       Date:  1971-04

8.  Progressive changes of Vibrio serotypes in germ-free mice infected with Vibrio cholerae.

Authors:  R B Sack; C E Miller
Journal:  J Bacteriol       Date:  1969-09       Impact factor: 3.490

9.  The occurrence of 4-amino-4-deoxy-L-arabinose as a constituent in Salmonella lipopolysaccharide preparations.

Authors:  W A Volk; C Galanos; O Lüderitz
Journal:  Eur J Biochem       Date:  1970-12

10.  Fine structure of Vibrio cholerae during toxin production.

Authors:  J R Kennedy; S H Richardson
Journal:  J Bacteriol       Date:  1969-12       Impact factor: 3.490

View more
  10 in total

1.  Comparison of Vibrio parahaemolyticus grown in estuarine water and rich medium.

Authors:  J Pace; T J Chai
Journal:  Appl Environ Microbiol       Date:  1989-08       Impact factor: 4.792

Review 2.  New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

Authors:  M M Levine; J B Kaper; R E Black; M L Clements
Journal:  Microbiol Rev       Date:  1983-12

3.  Preparation, immunogenicity, and protective efficacy, in a murine model, of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid.

Authors:  A Boutonnier; S Villeneuve; F Nato; B Dassy; J M Fournier
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

4.  Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a.

Authors:  C O Tacket; B Forrest; R Morona; S R Attridge; J LaBrooy; B D Tall; M Reymann; D Rowley; M M Levine
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

5.  Characterization of Vibrio cholerae O1 El tor galU and galE mutants: influence on lipopolysaccharide structure, colonization, and biofilm formation.

Authors:  J Nesper; C M Lauriano; K E Klose; D Kapfhammer; A Kraiss; J Reidl
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

6.  Assay dependent specificities of monoclonal antibodies to bacterial antigens.

Authors:  S Ghosh; A M Campbell
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

7.  Characterization of surface properties of Vibrio cholerae.

Authors:  S Kabir; S Ali
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

8.  Identification of plasmid-encoded mannose-resistant hemagglutinin and HEp-2 and HeLa cell adherence factors of two diarrheagenic Escherichia coli strains belonging to an enteropathogenic serogroup.

Authors:  R Pal; A C Ghose
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

9.  Elucidation of a novel Vibrio cholerae lipid A secondary hydroxy-acyltransferase and its role in innate immune recognition.

Authors:  Jessica V Hankins; James A Madsen; David K Giles; Brandon M Childers; Karl E Klose; Jennifer S Brodbelt; M Stephen Trent
Journal:  Mol Microbiol       Date:  2011-07-18       Impact factor: 3.501

10.  Glucose- but not rice-based oral rehydration therapy enhances the production of virulence determinants in the human pathogen Vibrio cholerae.

Authors:  Juliane Kühn; Flavio Finger; Enrico Bertuzzo; Sandrine Borgeaud; Marino Gatto; Andrea Rinaldo; Melanie Blokesch
Journal:  PLoS Negl Trop Dis       Date:  2014-12-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.